Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical research

Ebola vaccine tested in 60 volunteers shows immune response

An Ebola vaccine being developed by GlaxoSmithKline generates an immune response, according to initial testing of the vaccine in 60 healthy volunteers.

Source: Shutterstock.com

The Ebola vaccine is being developed against the Zaire strain of Ebola, which is circulating in West Africa

An Ebola vaccine being developed by GlaxoSmithKline and the US National Institutes of Health is well tolerated and generates an immune response, according to initial testing of the vaccine in 60 healthy volunteers.

The vaccine candidate, known as ‘ChAd3’, uses a single Ebola virus gene delivered by a chimpanzee adenovirus-3 vector. It is designed to target the Zaire strain of Ebola, which is responsible for the current outbreak in West Africa that has caused more than 8,500 deaths.

Three doses of ChAd3 were tested, with volunteers being given a single dose and assessed for 4 weeks. At all doses, antibody and T-cell responses were detected and there were no safety concerns, according to the report published in The New England Journal of Medicine (online, 28 January 2015)[1]. The vaccine will now be assessed in larger-scale studies in West Africa. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067799

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Hospital Pre-registration Pharmacist Training

    Hospital Pre-registration Pharmacist Training

    A practical explanation for undergraduates and pre-registration trainees. Shows what to expect from a hospital pre-registration pharmacist training programme.

    £25.00Buy now
  • Basic Pharmacokinetics

    Basic Pharmacokinetics

    A clear and concise basic pharmacokinetics textbook. Shows how to apply the principles to achieve successful drug therapy.

    £54.00Buy now
  • Pharmacy OSCEs

    Pharmacy OSCEs

    The only pharmacy-specific OSCE revision guide. This easy-to-use book covers the key competencies that will be tested in your exams.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • An Ebola vaccine being developed by GlaxoSmithKline generates an immune response, according to initial testing of the vaccine in 60 healthy volunteers.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.